L532-1829 Screening compound: N-tert-butyl-6-(4-ethylphenyl)-2-{4-[(pyridin-2-yl)methyl]piperazin-1-yl}imidazo[2,1-b][1,3,4]thiadiazol-5-amine

L532-1829 Screening compound: N-tert-butyl-6-(4-ethylphenyl)-2-{4-[(pyridin-2-yl)methyl]piperazin-1-yl}imidazo[2,1-b][1,3,4]thiadiazol-5-amine
L532-1829 Screening compound: N-tert-butyl-6-(4-ethylphenyl)-2-{4-[(pyridin-2-yl)methyl]piperazin-1-yl}imidazo[2,1-b][1,3,4]thiadiazol-5-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound L532-1829
N-tert-butyl-6-(4-ethylphenyl)-2-{4-[(pyridin-2-yl)methyl]piperazin-1-yl}imidazo[2,1-b][1,3,4]thiadiazol-5-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L532-1829

Molecular Formula

C26H33N7S (C26 H33 N7 S)

Compound Name

N-tert-butyl-6-(4-ethylphenyl)-2-{4-[(pyridin-2-yl)methyl]piperazin-1-yl}imidazo[2,1-b][1,3,4]thiadiazol-5-amine

IUPAC name

N-tert-butyl-6-(4-ethylphenyl)-2-{4-[(pyridin-2-yl)methyl]piperazin-1-yl}imidazo[21-b][134]thiadiazol-5-amine

SMILES

CCc(cc1)ccc1-c1c(NC(C)(C)C)n2nc(N3CCN(Cc4ncccc4)CC3)sc2n1

InChI

InChI=1S/C26H33N7S/c1-5-19-9-11-20(12-10-19)22-23(29-26(2,3)4)33-24(28-22)34-25(30-33)32-16-14-31(15-17-32)18-21-8-6-7-13-27-21/h6-13,29H,5,14-18H2,1-4H3

InChI Key

ZZBODFCKKRULBC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27459917

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.66

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.069

Distribution Coefficient, logD

5.029

Water Solubility, LogSw

-4.58

Polar Surface Area

46.863

Acid Dissociation Constant (pKa)

21.97

Base Dissociation Constant (pKb)

6.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

L532-1829 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L532-1829 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L532-1829?
Check Price and Availability of L532-1829, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L532-1829 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L532-1829
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L532-1829
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L532-1829 available by request